Chemical Week Magazine :: Other
U.S. Regulations Take Shape for Follow-On Biologics
1:34 PM MDT | August 6, 2007 | Alex Scott
Bipartisan members of Congress were working toward an agreement on new regulations at CW’s press time last week that could enable the swift approval in the U.S. of generic biologic drugs, otherwise known as biogenerics or follow-on biologics. The regulations could open the door to a wave of lower-cost biotech drugs. Prospects for a new bill to facilitate the introduction of biogenerics have improved since the Democrats took control of Congress, industry representatives say. The U.S. FDA says it would welcome a new biogenerics bill. Janet Woodcock...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee